X-linked inhibitor of apoptosis (XIAP) deficiency: The spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis

Clinical Immunology

Volumn 149, Issue 1, 2013, Pages 133-141

  Speckmann, C ^a   Lehmberg, K ^b   Albert, M H ^c   Damgaard, R B ^d   Fritsch, M ^d,e   Gyrd Hansen, M ^d   Rensing Ehl, A ^a   Vraetz, T ^a   Grimbacher, B ^a,f   Salzer, U ^a   Fuchs, I ^a   Ufheil, H ^a   Belohradsky, B H ^c   Hassan, A ^g   Cale, C M ^g   Elawad, M ^g   Strahm, B ^a   Schibli, S ^h   Lauten, M ⁱ   Kohl, M ⁱ   Meerpohl, J J ^a   Rodeck, B ^j   Kolb, R ^k   Eberl, W ^l   Soerensen, J ^m   von Bernuth, H ⁿ   Lorenz, M ^o   Schwarz, K ^o   zur Stadt, U ^b   Ehl, S ^a   more..

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d University of Copenhagen   (Denmark)

^e UNIVERSITY OF COLOGNE   (Germany)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

ⁱ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^j MarienHospital Osnabruck   (Germany)

^k KLINIKUM OLDENBURG   (Germany)

^l KLINIKUM BRAUNSCHWEIG   (Germany)

^m UNIVERSITY HOSPITAL FRANKFURT   (Germany)

ⁿ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^o UNIVERSITY HOSPITAL ULM   (Germany)

more..

Author keywords

BIRC4; Hematopoietic stem cell transplantation; Hemophagocytic lymphohistiocytosis; Inflammatory bowel disease; XIAP

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; FLOW CYTOMETRY; HEMOPHAGOCYTIC SYNDROME; HUMAN; HUMORAL IMMUNE DEFICIENCY; MONONUCLEOSIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RECURRENT FEVER; SKIN ABSCESS; SKIN FISTULA; SPLENOMEGALY; UVEITIS; X LINKED INHIBITOR OF APOPTOSIS DEFICIENCY;

BIRC4; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; INFLAMMATORY BOWEL DISEASE; XIAP;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; GENOTYPE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MUTATION; NATURAL KILLER T-CELLS; PHENOTYPE; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN; YOUNG ADULT;

EID: 84883228121     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.07.004     Document Type: Article

References (23)

1. Rigaud S., Fondanèche M.-C., Lambert N., Pasquier B., Mateo V., Soulas P., Galicier L., Le Deist F., Rieux-Laucat F., Revy P., Fischer A., de Saint-Basile G., Latour S. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006, 444:110-114.
2. Nichols K.E., Harkin D.P., Levitz S., Krainer M., Kolquist K.A., Genovese C., Bernard A., Ferguson M., Zuo L., Snyder E., Buckler A.J., Wise C., Ashley J., Lovett M., Valentine M.B., Look A.T., Gerald W., Housman D.E., Haber D.A. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:13765-13770.
3. Coffey A.J., Brooksbank R.A., Brandau O., Oohashi T., Howell G.R., Bye J.M., Cahn A.P., Durham J., Heath P., Wray P., Pavitt R., Wilkinson J., Leversha M., Huckle E., Shaw-Smith C.J., Dunham A., Rhodes S., Schuster V., Porta G., Yin L., Serafini P., Sylla B., Zollo M., Franco B., Bolino A., Seri M., Lanyi A., Davis J.R., Webster D., Harris A., Lenoir G., de St Basile G., Jones A., Behloradsky B.H., Achatz H., Murken J., Fassler R., Sumegi J., Romeo G., Vaudin M., Ross M.T., Meindl A., Bentley D.R. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 1998, 20:129-135.
4. Sayos J., Wu C., Morra M., Wang N., Zhang X., Allen D., van Schaik S., Notarangelo L., Geha R., Roncarolo M.G., Oettgen H., De Vries J.E., Aversa G., Terhorst C. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998, 395:462-469.
5. Pachlopnik Schmid J., Canioni D., Moshous D., Touzot F., Mahlaoui N., Hauck F., Kanegane H., Lopez-Granados E., Mejstrikova E., Pellier I., Galicier L., Galambrun C., Barlogis V., Bordigoni P., Fourmaintraux A., Hamidou M., Dabadie A., Le Deist F., Haerynck F., Ouachée-Chardin M., Rohrlich P., Stephan J.-L., Lenoir C., Rigaud S., Lambert N., Milili M., Schiff C., Chapel H., Picard C., de Saint-Basile G., Blanche S., Fischer A., Latour S. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1. Blood 2011, 117:1522-1529.
6. Marsh R.A., Madden L., Kitchen B.J., Mody R., McClimon B., Jordan M.B., Bleesing J.J., Zhang K., Filipovich A.H. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood 2010, 116:1079-1082.
7. Filipovich A.H., Zhang K., Snow A.L., Marsh R.A. X-linked lymphoproliferative syndromes: brothers or distant cousins?. Blood 2010, 116:3398-3408.
8. Worthey E.A., Mayer A.N., Syverson G.D., Helbling D., Bonacci B.B., Decker B., Serpe J.M., Dasu T., Tschannen M.R., Veith R.L., Basehore M.J., Broeckel U., Tomita-Mitchell A., Arca M.J., Casper J.T., Margolis D.A., Bick D.P., Hessner M.J., Routes J.M., Verbsky J.W., Jacob H.J., Dimmock D.P. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet. Med. 2011, 13:255-262.
9. Yang X., Kanegane H., Nishida N., Imamura T., Hamamoto K., Miyashita R., Imai K., Nonoyama S., Sanayama K., Yamaide A., Kato F., Nagai K., Ishii E., van Zelm M.C., Latour S., Zhao X.-D., Miyawaki T. Clinical and genetic characteristics of XIAP deficiency in Japan. J. Clin. Immunol. 2012, 32:411-420.
10. Marsh R.A., Rao K., Satwani P., Lehmberg K., Müller I., Li D., Kim M.-O., Fischer A., Latour S., Sedlacek P., Barlogis V., Hamamoto K., Kanegane H., Milanovich S., Margolis D.A., Dimmock D., Casper J., Douglas D.N., Amrolia P.J., Veys P., Kumar A.R., Jordan M.B., Bleesing J.J., Filipovich A.H. Outcome of hematopoietic stem cell transplantation for adenosine deaminase deficient severe combined immunodeficiency. Blood 2012, 121:877-883.
11. Bryceson Y.T., Pende D., Maul-Pavicic A., Gilmour K.C., Ufheil H., Vraetz T., Chiang S.C., Marcenaro S., Meazza R., Bondzio I., Walshe D., Janka G., Lehmberg K., Beutel K., zur Stadt U., Binder N., Arico M., Moretta L., Henter J.-I., Ehl S. A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. Blood 2012, 119:2754-2763.
12. Marsh R.A., Villanueva J., Kim M.-O., Zhang K., Marmer D., Risma K.A., Jordan M.B., Bleesing J.J., Filipovich A.H. Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. Clin. Immunol. 2009, 132:116-123.
13. Horn P.C., Belohradsky B.H., Urban C., Weber-Mzell D., Meindl A., Schuster V. Two new families with X-linked inhibitor of apoptosis deficiency and a review of all 26 published cases. J. Allergy Clin. Immunol. 2011, 127:544-546.
14. Cunningham-Rundles C. Autoimmunity in primary immune deficiency: taking lessons from our patients. Clin. Exp. Immunol. 2011, 164(Suppl. 2):6-11.
15. Gambineri E., Torgerson T.R. Genetic disorders with immune dysregulation. Cell. Mol. Life Sci. 2012, 69:49-58.
16. Glocker E.-O., Kotlarz D., Boztug K., Gertz E.M., Schäffer A.A., Noyan F., Perro M., Diestelhorst J., Allroth A., Murugan D., Hätscher N., Pfeifer D., Sykora K.-W., Sauer M., Kreipe H., Lacher M., Nustede R., Woellner C., Baumann U., Salzer U., Koletzko S., Shah N., Segal A.W., Sauerbrey A., Buderus S., Snapper S.B., Grimbacher B., Klein C. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 2009, 361:2033-2045.
17. Glocker E.-O., Kotlarz D., Klein C., Shah N., Grimbacher B. IL-10 and IL-10 receptor defects in humans. Ann. N. Y. Acad. Sci. 2011, 1246:102-107.
18. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cézard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
19. Philpott D.J., Girardin S.E. Crohn's disease-associated Nod2 mutants reduce IL10 transcription. Nat. Immunol. 2009, 10:455-457.
20. Noguchi E., Homma Y., Kang X., Netea M.G., Ma X. A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1. Nat. Immunol. 2009, 10:471-479.
21. Damgaard R.B., Nachbur U., Yabal M., Wong W.W.-L., Fiil B.K., Kastirr M., Rieser E., Rickard J.A., Bankovacki A., Peschel C., Ruland J., Bekker-Jensen S., Mailand N., Kaufmann T., Strasser A., Walczak H., Silke J., Jost P.J., Gyrd-Hansen M. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity. Mol. Cell 2012, 46:746-758.
22. Marsh R.A., Bleesing J.J., Filipovich A.H. Flow cytometric measurement of SLAM-associated protein and X-linked inhibitor of apoptosis. Methods Mol. Biol. 2013, 979:189-197.
23. Gyrd-Hansen M., Meier P. IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat. Rev. Cancer 2010, 10:561-574.